New search | Conferencedetail
mail
Print view
 
 

1st Rare and Genetic Neurodegenerative Drug Development Summit

Evvnt Promotion / evvnt
-
22.06.2022 - 23.06.2022  Online
Time: 08:50 - 16:00
 
Conference themes
Advance Life-Changing Therapies for Adolescents and Adults With Rare Neurological Disorders

Welcome to the 1st Rare and Genetic Neurodegenerative Drug Development Summit! This trailblazing meeting will be discussing, debating and exploring pivotal rare and genetic neurodegenerative disease research making industry news headlines.

Pioneers in this exclusive industry are convening online, this June, to network and learn from experts in pharma, biotech and academia.
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Anka G. Ehrhardt, Director, Cell-Based Assays / Analytical Research and Development, Merck, Christopher Missling, President and Chief, Executive Officer, Anavex Life Sciences, David Theron, Development Director in Neurology, Servier & more
 

Enquiries and Registration:

https://go.evvnt.com/1056250-2?pid=4832
Mr. Hanson Wade
 
Categories
General Medicine
Languages
English
Congress fees
Drug Developer Pricing - Conference Pass: USD 2099.0, Solution Provider Pricing - Conference Pass: USD 2599.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WienCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioCenter of ExcellenceAMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthAnästhesie in Entwicklungsländern e. V.Ärzte der WeltÖsterreichische Akademie der Ärzte